Ai L, Li Y, Liu Z, Li R, Wang X, Hai B. Tempol attenuates chronic intermittent hypoxia-induced lung injury through the miR-145-5p/Nrf2 signaling pathway: Tempol mitigates lung injury via miR-145-5p/Nrf2 pathway. Cell Mol Biol (Noisy-le-grand) [Internet]. 2023 Dec. 10 [cited 2024 Nov. 24];69(13):225-34. Available from: https://cellmolbiol.org/index.php/CMB/article/view/5099